Views & Analysis The first ever ‘artificial pancreas’ is here - the iPhone of... Medtronic's hybrid closed loop device is the first step towards a true 'artificial pancreas'
News Bigfoot Biomedical begins first artificial pancreas trial Trial will take place in three sites across the US.
News Medtronic to buy HeartWare, expand heart failure portfolio Deal worth an estimated $1.1 billion.
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
